Document Detail


High risk of cardiovascular disease in iron overload patients.
MedLine Citation:
PMID:  21128934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Iron overload (IO) is defined as an increase in storage iron, regardless of the presence or absence of tissue damage. Whether increased iron stores are involved in the pathogenesis of cardiovascular disease remains controversial.
OBJECTIVES:  To study insulin resistance markers, lipoprotein profile, activities of anti and prooxidant enzymes and cholesteryl ester transfer protein (CETP) in patients with IO.
METHODS: Twenty male patients with IO were compared with 20 sex- and age-matched controls. General biochemical parameters, lipoprotein profile, and activities of paraoxonase 1, employing two substrates, paraoxon (PON) and phenylacetate (ARE), lipoprotein-associated phospholipase A(2) (Lp-PLA(2) ) and CETP were determined.
RESULTS: IO patients showed higher levels of HOMA-IR and triglycerides [median (Q1-Q3)] [128 (93-193) vs. 79(51-91) mg dL(-1) , P < 0·0005] while lower high-density lipoprotein (HDL) cholesterol (mean ± SD) (41 ± 9 vs. 52 ± 10 mg dL(-1) , P < 0·0005) in comparison with controls. Moreover, the triglycerides/HDL-cholesterol [3·2 (2·0-5·1) vs. 1·5 (1·0-1·9), P < 0·0005] ratio and oxidized low-density lipoprotein levels [94 (64-103) vs. 68 (59-70) IU L(-1) , P < 0·05] were increased in the patient group. Although no difference was observed in ARE activity, PON activity was decreased in IO patients [246 (127-410) vs. 428 (263-516) nmol mL(-1) min(-1) , P < 0·05]. In addition, CETP and Lp-PLA(2) activities were also increased in the patients (189 ± 31 vs. 155 ± 36% ml(-1)  h(-1) , P < 0·005; and 10·1 ± 2·9 vs. 8·2 ± 2·4 μmol mL(-1) h(-1) , P < 0·05, respectively). Associations between ferritin concentration and the alterations in lipid metabolism were also found. Multiple regression analyses identified HOMA-IR as independent predictor of CETP activity (B = 65·9, P < 0·0001, r(2) = 0·35), as well as ferritin concentration of Lp-PLA(2) activity (B = 3·7, P < 0·0001, r(2) = 0·40) after adjusting for confounding variables.
CONCLUSIONS:   IO patients presented not only insulin resistance but also metabolic alterations that were related to elevated iron stores and are associated with high risk of cardiovascular disease.
Authors:
Tomás Meroño; Leonardo Gómez; Leonardo G Rosso; Patricia Sorroche; Laura Boero; Jorge Arbelbide; Fernando Brites
Related Documents :
2136344 - Prospective trial comparing a combination ph probe-nasogastric tube with aspirated gast...
21136524 - Reversible fanconi syndrome in a pediatric patient on deferasirox.
2868204 - Oesophageal spasm in patients with coronary artery spasm.
3608334 - Enterogastric reflux in suspected acute cholecystitis.
19226274 - Chemokine cc-ligand 5 production and eosinophil activation into the upper airways of as...
2768954 - Hemodynamic alterations in hemiplegic patients as a cause of edema in lower extremities.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-12-03
Journal Detail:
Title:  European journal of clinical investigation     Volume:  41     ISSN:  1365-2362     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-06     Completed Date:  2011-08-12     Revised Date:  2013-09-13    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  479-86     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.
Affiliation:
Tomàs Meroño, Department of Clinical Biochemistry, School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. tomasmero@yahoo.com.ar
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Argentina
Aryldialkylphosphatase / metabolism
Cardiovascular Diseases / metabolism*
Case-Control Studies
Cholesterol Ester Transfer Proteins / metabolism
Humans
Insulin Resistance
Iron Overload / metabolism*
Lipoproteins / metabolism
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Cholesterol Ester Transfer Proteins; 0/Lipoproteins; EC 3.1.8.1/Aryldialkylphosphatase; EC 3.1.8.1/PON1 protein, human
Comments/Corrections
Erratum In:
Eur J Clin Invest. 2013 Aug;43(8):895
Note: Rosso, Leonardo G [corrected to Gómez, Leonardo]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical outcomes of ESD for early gastric neoplasms in elderly patients.
Next Document:  Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats.